Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Therapeutic Drug Carrier Systems
Factor de Impacto: 2.9 Factor de Impacto de 5 años: 3.72 SJR: 0.573 SNIP: 0.551 CiteScore™: 2.43

ISSN Imprimir: 0743-4863
ISSN En Línea: 2162-660X

Volumes:
Volumen 36, 2019 Volumen 35, 2018 Volumen 34, 2017 Volumen 33, 2016 Volumen 32, 2015 Volumen 31, 2014 Volumen 30, 2013 Volumen 29, 2012 Volumen 28, 2011 Volumen 27, 2010 Volumen 26, 2009 Volumen 25, 2008 Volumen 24, 2007 Volumen 23, 2006 Volumen 22, 2005 Volumen 21, 2004 Volumen 20, 2003 Volumen 19, 2002 Volumen 18, 2001 Volumen 17, 2000 Volumen 16, 1999 Volumen 15, 1998 Volumen 14, 1997 Volumen 13, 1996 Volumen 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v18.i6.50
40 pages

Complement Activation-Related Pseudoallergy Caused by Liposomes, Micellar Carriers of Intravenous Drugs, and Radiocontrast Agents

Janos Szebeni
Department of Membrane Biochemistry, Walter Reed Army Institute of Research, 503 Robert Grant Avenue Silver Spring, MD 20910-7580

SINOPSIS

There is growing awareness that numerous drug-induced immediate hypersensitivity reactions (HSRs) do not fit in Gell and Coombs’ Type I category of drug allergies, characterized by the pivotal pathogenic role of allergen-specific IgE. Such non-IgE-mediated “pseudoallergic” reactions are primarily caused by (1) certain liposomal formulations of intravenous drugs and imaging agents, (2) infusion liquids containing micelle-forming amphiphilic lipids or synthetic block-copolymer emulsifiers, and (3) iodinated radiocontrast media with limited solubility in water. Common features of the latter “pseudoallergens” include the capacity to activate the complement (C) system; also, the symptoms they cause are often typical manifestations of excessive anaphylatoxin generation in blood. Hence, these reactions have been called “C activation-related pseudoallergy” (CARPA). The present review surveys the experimental and clinical evidence for the involvement of C activation in HSRs caused by pseudoallergens in the above three categories. To fit CARPA within the classical scheme of HSRs, a subdivision of Type I allergy is proposed on the basis of the mechanism of mast cell (and basophil) activation. The new scheme distinguishes direct and receptor-mediated HSRs, with the latter category subdivided to true IgE-mediated allergy; anaphylatoxin-mediated CARPA; and IgE plus anaphylatoxin double-triggered reactions. Further issues addressed in the review include animal models, risk factors, laboratory predictive tests, and pharmacological prevention of CARPA.


Articles with similar content:

The Role of T Cells in Kawasaki Disease
Critical Reviews™ in Immunology, Vol.15, 1995, issue 3-4
Raphael Hirsch, Jaime de Inocencio
Nucleic Acid Modulation of Gene Expression: Approaches for Nucleic Acid Therapeutics Against Cancer
Critical Reviews™ in Eukaryotic Gene Expression, Vol.15, 2005, issue 2
Yuji Nakata, Susan Shetzline, Alan M. Gewirtz, Tae-Kon Kim
EVALUATION OF MYOCARDIAL PERFUSION BY CONTRAST ECHOCARDIOGRAPHY
ICHMT DIGITAL LIBRARY ONLINE, Vol.18, 1992, issue
Diana Rinkiewich, Rafael Beyar, Samuel Sideman, Walter Markiewicz, Shimon Reisner
Cytokine Involvement in Cancer Anorexia/ Cachexia: Role of Megestrol Acetate and Medroxyprogesterone Acetate on Cytokine Downregulation and Improvement of Clinical Symptoms
Critical Reviews™ in Oncogenesis, Vol.9, 1998, issue 2
Maria Cristina Santona, Elena Massa, Paoia Lai, Giovanni Mantovani, Massimo Ghiani, Antonio Maccio
The Granule Pathway of Programmed Cell Death
Critical Reviews™ in Immunology, Vol.25, 2005, issue 3
Philip G. Ashton-Rickardt